The Deloitte Center for Health Solutions issues a report examine how health plans are doing from a financial perspective. (Deloitte Report) This report looks at fully-insured performance; that is, when the health plan accepts a premium in exchange for taking full risk on the medical expenses. Four lines of business are considered: commercial group, commercial individual, Medicare and Medicaid. These fully insured plans covered 57% of Americans in 2016. The data source was the National Association of Insurance Commissioner reports filed by health plans in the states, which is a pretty reliable source, with good definitions. During the five years from 2011 to 2016, revenue for this kind of business for the 238 plans in the study rose 55%, and enrollment grew 29%, from 143 million to 184 million; but underwriting gains were 29% less in 2016 than in 2011. In 2011, underwriting gains were $19.2 billion and in 2016 they were $13.6 billion. The underwriting margin was 3.5% in 2011 and 1.6% in 2016. There was a decrease in average profit margins and more plans had annual losses. The largest plans are doing the best; in 2016 the three largest plans by revenue had 84% of all underwriting gains. As you would expect and hope, for-profit plans were growing faster and had higher margins than did non-profit ones. The performance of plans also began to show greater variation, with the gap between the best and worst performing plans increasing. Those top three plans in every year were UnitedHealth Group, Kaiser Foundation, and Anthem, in order, with Aetna, Centene, Cigna, Humana and HCSC also always being in the top ten each year. While the top three had strong underwriting performance, their share of all enrollment dropped from 33% in 2011 to 30% in 2016. The great majority of all health plans are pretty small and these smaller plans have worse underwriting performance. The study did not examine performance by line of business, but I strongly suspect that the individual business is driving the lower underwriting margins. I would guess that group performance is about the same, Medicare performance improved slightly and Medicaid performance declined slightly. Overall, for the top dogs life looks good and for others it is a dog-eat-dog world.
✅ Subscribe via Email
About this Blog
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at [email protected].
Healthy Skeptic Podcast
This is an outstanding report on total global drug spending and trends, with projections out to 2025. It helps you understand this important area of health care, which does much...
June 1, 2021
MedPAC 2019 Report to Congress
June 18, 2019
What do you get when you combine a company with a commodity business model, that out of desperation massively overpays for another company that has a commodity business model? $10...
July 27, 2022
The “stupid” model for health care venture capital investing is alive and well. Everside health, which operates primary care clinics and has grown by acquiring other failing health care businesses,...
July 26, 2022
Apparently not even a cute name can save you if you have a stupid business. I constantly bemoan the mis-application of capital and health care is Exhibit A. Olive, another...
July 26, 2022
Access ACO Care Management Chronic Disease Comparative Effectiveness Consumer Directed Health Consumers Devices Disease Management Drugs EHRs Elder Care End-of-Life Care FDA Financings Genomics Government Health Care Costs Health Care Quality Health Care Reform Health Insurance Health Insurance Exchange HIT HomeCare Hospital Hospital Readmissions Legislation M&A Malpractice Meaningful Use Medicaid Medical Care Medicare Medicare Advantage Mobile Pay For Performance Pharmaceutical Physicians Providers Regulation Repealing Reform Telehealth Telemedicine Wellness and Prevention Workplace